Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

christian_dillon

Christian Dillon announced as Vice President of Biology at PhoreMost

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …
Appointment
serap_becker

Ashfield Engage appoints new Head of Patient Solutions

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …
Appointment
pers

Personalised medicine in oncology: Where are we now?

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Feature

Novartis appoints Alessandra Dorigo as General Manager

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Appointment
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
Feature

“Worst drug approval decision in recent US history”

June 30, 2021 Research and Development

The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …
News
img_4190-e1376666350337-web

Sickle cell therapy granted innovation passport by MHRA

June 30, 2021 Research and Development MHRA, SCD, brexit

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
News
bms_european_hq_in_rueil_1

EU approves BMS’s treatment for metastatic colorectal cancer

June 30, 2021 Research and Development

The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …
News
xxx

RNA breakthrough: Fluorescence used to track molecule movement

June 30, 2021 Research and Development AstraZeneca, RNA, mrna

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
News

EU approves Merck’s treatment for oesophageal cancer

June 30, 2021 Research and Development

The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …
News

Anti-parasitic drug investigated as potential COVID treatment

June 23, 2021 Research and Development

The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …
News
astrazeneca_sign_sky

AstraZeneca’s lung cancer treatment approved in China

June 23, 2021 Research and Development

AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …
News
european_commission_web

Extra 150 million doses of Moderna COVID jab bought by EC

June 23, 2021 Research and Development

Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …
News
janssen_latest_logo_on_sign_closer

EU approves Janssen’s treatments for amyloidosis and multiple myeloma

June 23, 2021 Research and Development

The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …
News

Vectura announces cannabinoid company collaboration for TBI treatment

June 23, 2021 Research and Development

Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026